Pay in 4 interest-free payments of $5.31 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Gotrade News - Pfizer just locked in a licensing deal with Sciwind Biosciences for a type 2 diabetes drug called ecnoglutide, with potential payouts reaching up to $495 million
[DOI] [PubMed] [Google Scholar] 44.Larsen S.B., Hanss Z., Krger R
doi: 10.3389/fphar.2024.1461398 Received 08 July 2024 Accepted 01 November 2024 Published 13 November 2024 Volume 15 - 2024 Edited by Daniele Maria-Ferreira, Instituto de Pesquisa Pel Pequeno Prncipe, Brazil Reviewed by Kimberly Crosby, University of Oklahoma, United States Marcelo Adrian Estrin, Interamerican Open University, Argentina Qiuxia Min, The First Peoples Hospital of Yunnan Province, China Updates Copyright 2024 Guo, Guo, Li and Wang
doi: 10.1080/23723556.2015.1054549 58
PMID: 11180282
US$ 27.13
US$ 26.53
US$ 25.05
US$ 21.79
US$ 21.68
US$ 24.39
